Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia

Area of Science:

• Neuroscience
• Cell Biology
• Pharmacology

Background:

• Microglia are key immune cells in the central nervous system.
• Opioid receptors, like the mu-opioid receptor (MOR), are present on microglia.
• Morphine's effects on microglia are not fully understood.

Purpose of the Study:

• To investigate the effects of morphine on microglial morphology, migration, and gene expression.
• To elucidate the signaling pathways involved in morphine-induced microglial responses.

Main Methods:

• Morphine treatment of cultured microglia and EOC 2 cell line.
• Assessment of cell morphology and membrane ruffling using phalloidin staining.
• Chemotaxis assays using Boyden chambers.
• Analysis of brain-derived neurotrophic factor (BDNF) gene expression.
• Western blotting for ERK1/2 phosphorylation.
• Inhibition studies using naloxone, pertussis toxin, wortmannin, and other inhibitors.

Main Results:

• Morphine (1 µM) induced morphological changes in microglia, including lamellipodia formation and membrane ruffling, colocalized with Rac.
• Morphine stimulated microglia chemotaxis at concentrations ≥ 1 µM.
• Morphine increased BDNF gene expression and ERK1/2 phosphorylation.
• Signaling pathways involved PI3Kγ and Rac for chemotaxis, and MOR-mediated metalloprotease activation for BDNF expression via ERK1/2.

Conclusions:

• Morphine significantly alters microglial morphology and function at high concentrations.
• Distinct signaling pathways mediate morphine's effects on microglial chemotaxis and BDNF gene expression.
• Understanding these pathways is crucial for comprehending opioid-induced neuroinflammation.